Determination of the efflux pump-mediated resistance prevalence in pseudomonas aeruginosa, using an efflux pump inhibitor

Current Microbiology

Volumn 59, Issue 3, 2009, Pages 352-355

  Tohidpour, Abolghasem ^a   Najar Peerayeh, Shahin ^a   Mehrabadi, Jalil F ^a   Rezaei Yazdi, Hadi ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; AMIKACIN; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PHENYLALANINE ARGINYL BETA NAPHTYLAMIDE; PIPERACILLIN; TICARCILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT, ACTIVE; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ENZYME INHIBITORS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 68849124201     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-009-9444-5     Document Type: Article

References (23)

1. T Akasaka M Tanaka A Yamagushi 2001 Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance J Antimicrob Chemother 45 2263 2268
2. Y Carmeli N Troillet G Eliopoulos 1999 Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents Antimicrob Agents Chemother 43 1379 1382
3. CLSI (2007) Performance standards for antimicrobial disk susceptibility tests; Approved Standard, 9th edn, M02-A9
4. CLSI (2007) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard, 7th edn, M07-A7
5. A Coban B Ekinci B Durupinar 2004 A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pesudomonas aeruginosa isolates Chemotherapy 50 22 26
6. JS Garner W Jarvis T Emori 1988 CDC definitions for nosocomial infections Am J Infect Control 16 128 140
7. L Gibson J Burns BW Ramsey 2003 Pathophysiology and management of pulmonary infections in cystic fibrosis Am J Respir Crit Care Med 168 918 951
8. JR Govan V Deretic 1996 Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia Microbiol Rev 60 539 574
9. REW Hancock 1998 Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria Clin Infect Dis 27 Suppl 1 S93 S99
10. C Hooper 1999 Mechanisms of fluoroquinolone resistance Drug Resist Updates 2 38 55
11. J Kriengkauykiat E Porter O Lomovskaya 2005 Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa Antimicrob Agents Chemother 49 565 570
12. JF Linares JA Lopez E Camafeita 2005 Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type iii secretion in Pseudomonas aeruginosa J Bacteriol 187 1384 1391
13. O Lomovskaya W Watkins 2001 Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria J Mol Microbiol Biotechnol 3 2 225 236
14. O Lomovskaya MS Warren A Lee 2001 Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy Antimicrob Agents Chemother 45 105 116
15. N Masuda E Sakagawa S Ohy 2000 Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXYOprM efflux pumps in Pseudomonas aeruginosa Antimicrob Agents Chemother 44 3322 3327
16. AJ Morrison RP Wenzel 1984 Epidemiology of infection due to Pseudomonas aeruginosa Rev Infect Dis 6 Suppl 3 627 642
17. National Nosocomial Infection Surveillance System (2004) National Nosocomial Infection Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470-485
18. M Pages M Masi J Barbe 2005 Inhibitors of efflux pumps in Gram-negative bacteria Trends Mol Med 8 382 389
19. K Poole 2000 Efflux-mediated resistance to fluoroquinolones in gram negative bacteria Antimicrob Agents Chemother 44 2233 2241
20. K Poole 2004 Efflux-mediated multiresistance in gram-negative bacteria Clin Microbiol Infect 10 12 26
21. K Poole 2005 Efflux-mediated antimicrobial resistance J Antimicrob Chemother 56 20 51
22. JP Quinn 1998 Clinical problems posed by multiresistant nonfermenting gram-negative pathogens Clin Infect Dis 27 S117 S124
23. MA Webber KJV Piddock 2003 The importance of efflux pumps in bacterial antibiotic resistance J Antimicrob Chemother 51 9 11